Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» IPOs
IPOs
Two Biopharmas Nix IPO Plans in Unstable Market
BioSpace
Thu, 10/21/21 - 11:18 pm
NASDAQ
IPOs
AEON Biopharma
Cingulate
IPO floodgates open up after summer lull as five more biotechs file for Nasdaq
Endpoints
Tue, 10/12/21 - 10:59 am
Evotec
Entrada Therapeutics
Aura Biosciences
Vaxxinity
Blue Water Vaccines
IPOs
Pfizer, Bayer-backed Pyxis ups IPO price as biotech's public run continues unabated
Fierce Biotech
Fri, 10/8/21 - 10:39 am
IPOs
Pyxis Oncology
Pfizer
Bayer
oncology
OrbiMed's TKI play makes its Nasdaq debut as Theseus prices IPO
Endpoints
Thu, 10/7/21 - 11:13 am
IPOs
Theseus Pharmaceuticals
OrbiMed
NASDAQ
Biotech listings show signs of a slowdown
EP Vantage
Wed, 10/6/21 - 10:38 am
IPOs
Adagio Therapeutics
Caribou Biosciences
Erasca
DiCE Therapeutics
Icosavax
This Recent Biologics IPO Could Be Heading Toward a Gain of 60% or More
Motley Fool, clinical trials,
Mon, 10/4/21 - 10:37 am
IPOs
drug delivery
Rani Therapeutics
The cash won't stop for Exscientia as it makes a $300M+ Nasdaq debut
Endpoints
Sun, 10/3/21 - 08:16 pm
Exscientia
IPOs
artificial intelligence
Covid has made biotech companies the hot new tech sector as investor demand drives record IPOs
CNBC
Fri, 10/1/21 - 10:42 am
biotech
IPOs
investors
A New Medtech IPO Could Be on the Way
Medical Devices and Diagnostics Industry
Tue, 09/28/21 - 12:03 am
Medtech
diagnostics
IPOs
PaveMed
spinoffs
Lucid Diagnostics
Cue Health, Google's COVID-19 test provider, raises $200M in an IPO
Medtech Dive
Mon, 09/27/21 - 10:56 am
Cue Health
Google
IPOs
diagnostics
Bankrolled by Pfizer and Bayer, Pyxis files for $100M IPO to take cancer drugs into the clinic
Fierce Pharma
Mon, 09/20/21 - 11:17 am
Pyxis Oncology
IPOs
Pfizer
Bayer
Three more biotechs hit Nasdaq as the sector, now with more than $13B raised, continues barreling toward record
Endpoints
Wed, 09/15/21 - 10:56 am
IPOs
SPACs
NASDAQ
Pasithea Therapeutics
Tyra Biosciences
DiCE Therapeutics
Five Life Sciences Companies Ramping up the Fall Flood of IPOs
BioSpace
Mon, 09/13/21 - 11:28 pm
IPOs
Exscientia
Sumitomo Dainippon Pharma
Cingluate
Tyra Biosciences
Procept BioRobotics
IPO filings are back on the biotech menu as an ADHD drug developer submits its Nasdaq paperwork
Endpoints
Fri, 09/10/21 - 11:12 am
IPOs
ADHD
Cingulate
After pandemic delay and a South Korean deal, Boston-area biotech raises Series B with sights on IPO
Endpoints
Thu, 08/26/21 - 10:59 am
Neurogastrx
IPOs
South Korea
Tyra Biosciences wants to bank $100M for an IPO
Fierce Biotech
Mon, 08/23/21 - 11:02 am
Tyra Biosciences
IPOs
Dermata Therapeutics prices ~$18M IPO
Seeking Alpha
Fri, 08/13/21 - 12:05 pm
Dermata Therapeutics
dermatology
IPOs
Virtually unknown mRNA upstart rides SPAC to Nasdaq with a $1.5B valuation as RA-backed neuro player prices IPO
Endpoints
Tue, 08/10/21 - 10:38 am
GreenLight Biosciences
SPAC
IPOs
MRNA
Bayer bets $1.5B that Vividion will help it target the 'undruggable' and make 1+1=3
Fierce Biotech
Thu, 08/5/21 - 11:11 am
Bayer
Vividion
M&A
IPOs
R&D
Icosavax’s $182M IPO haul is key for RSV, but eyes are on its Covid vaccine too
MedCity News
Sun, 08/1/21 - 11:53 pm
IPOs
Icosavax
RSV
vaccines
Pages
« first
‹ previous
…
7
8
9
10
11
12
13
14
15
…
next ›
last »